MDGL
Price
$436.70
Change
+$11.64 (+2.74%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
9.74B
63 days until earnings call
NAGE
Price
$9.81
Change
+$0.04 (+0.41%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
783.17M
62 days until earnings call
Interact to see
Advertisement

MDGL vs NAGE

Header iconMDGL vs NAGE Comparison
Open Charts MDGL vs NAGEBanner chart's image
Madrigal Pharmaceuticals
Price$436.70
Change+$11.64 (+2.74%)
Volume$2.1K
Capitalization9.74B
Niagen Bioscience
Price$9.81
Change+$0.04 (+0.41%)
Volume$6.83K
Capitalization783.17M
MDGL vs NAGE Comparison Chart in %
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. NAGE commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Buy and NAGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (MDGL: $425.06 vs. NAGE: $9.77)
Brand notoriety: MDGL and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 103% vs. NAGE: 46%
Market capitalization -- MDGL: $9.74B vs. NAGE: $783.17M
MDGL [@Biotechnology] is valued at $9.74B. NAGE’s [@Biotechnology] market capitalization is $783.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, both MDGL and NAGE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 6 TA indicator(s) are bullish while NAGE’s TA Score has 4 bullish TA indicator(s).

  • MDGL’s TA Score: 6 bullish, 3 bearish.
  • NAGE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than NAGE.

Price Growth

MDGL (@Biotechnology) experienced а +8.53% price change this week, while NAGE (@Biotechnology) price change was +1.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

MDGL is expected to report earnings on Oct 30, 2025.

NAGE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($9.74B) has a higher market cap than NAGE($783M). NAGE YTD gains are higher at: 84.072 vs. MDGL (37.752). NAGE has higher annual earnings (EBITDA): 18.1M vs. MDGL (-266.74M). MDGL has more cash in the bank: 797M vs. NAGE (60.3M). NAGE has less debt than MDGL: NAGE (3.29M) vs MDGL (124M). MDGL has higher revenues than NAGE: MDGL (516M) vs NAGE (116M).
MDGLNAGEMDGL / NAGE
Capitalization9.74B783M1,244%
EBITDA-266.74M18.1M-1,474%
Gain YTD37.75284.07245%
P/E RatioN/A44.64-
Revenue516M116M445%
Total Cash797M60.3M1,322%
Total Debt124M3.29M3,767%
FUNDAMENTALS RATINGS
MDGL vs NAGE: Fundamental Ratings
MDGL
NAGE
OUTLOOK RATING
1..100
2724
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
2778
SMR RATING
1..100
9625
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDGL's Valuation (67) in the Pharmaceuticals Other industry is in the same range as NAGE (76) in the Chemicals Specialty industry. This means that MDGL’s stock grew similarly to NAGE’s over the last 12 months.

MDGL's Profit vs Risk Rating (27) in the Pharmaceuticals Other industry is somewhat better than the same rating for NAGE (78) in the Chemicals Specialty industry. This means that MDGL’s stock grew somewhat faster than NAGE’s over the last 12 months.

NAGE's SMR Rating (25) in the Chemicals Specialty industry is significantly better than the same rating for MDGL (96) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew significantly faster than MDGL’s over the last 12 months.

NAGE's Price Growth Rating (37) in the Chemicals Specialty industry is in the same range as MDGL (37) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to MDGL’s over the last 12 months.

NAGE's P/E Growth Rating (100) in the Chemicals Specialty industry is in the same range as MDGL (100) in the Pharmaceuticals Other industry. This means that NAGE’s stock grew similarly to MDGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDGLNAGE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
57%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
80%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLBFX37.690.07
+0.19%
American Funds American Balanced R5
NNLEX25.60N/A
N/A
Nicholas Limited Edition N
FCVCX16.92N/A
N/A
Fidelity Advisor Small Cap Value C
TCMIX18.77N/A
N/A
AMG TimesSquare International SmallCap Z
APHTX25.57-0.01
-0.04%
Artisan Focus Fund Institutional

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with IRON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-2.74%
IRON - NAGE
45%
Loosely correlated
+0.28%
MDGL - NAGE
45%
Loosely correlated
+0.05%
AXON - NAGE
43%
Loosely correlated
+0.09%
AMRN - NAGE
35%
Loosely correlated
-0.45%
CYTK - NAGE
35%
Loosely correlated
-0.94%
More